APA (7th ed.) Citation

Cui, Z., Huang, F., Fang, K., Yan, J., Zhang, Y., Kang, D. D., . . . Wang, Q. (2025). SCORT–Cas13d Nanotherapy Precisely Targets the 'Undruggable' Transcription Factor HoxB13 in Metastatic Prostate Cancer In Vivo. Advanced Science, 12(23), 1. https://doi.org/10.1002/advs.202417605

Chicago Style (17th ed.) Citation

Cui, Zhifen, et al. "SCORT–Cas13d Nanotherapy Precisely Targets the 'Undruggable' Transcription Factor HoxB13 in Metastatic Prostate Cancer In Vivo." Advanced Science 12, no. 23 (2025): 1. https://doi.org/10.1002/advs.202417605.

MLA (9th ed.) Citation

Cui, Zhifen, et al. "SCORT–Cas13d Nanotherapy Precisely Targets the 'Undruggable' Transcription Factor HoxB13 in Metastatic Prostate Cancer In Vivo." Advanced Science, vol. 12, no. 23, 2025, p. 1, https://doi.org/10.1002/advs.202417605.